Replies to post #201224 on Xechem International Inc. (fka XKEM)

[chillypepper]

yes ,foxwoodsfan , you are right , and clear post ,but the one who always says the right is not accepeted here ,,,

[Thrill Seeker]

I am fighting for the 20+ million people worldwide that have scd of which 80% can afford Nicosan and have been looking for such a treatment most of their life. I am especially fighting for children with scd. I am fighting for the Nigerian community who is heavily hammered by this disease and can produce an indigenous treatment that will benefit them medically and economically. Who are you fighting for ?

[wEaReLeGiOn]

Well Foxwood, you've made some good points in this post.

I believe there to be a niche market for 'Nicosan', or at least there was at a certain point in time, insofar as investors were concerned.

The reason I say it's a niche market, is at least two-fold. The natural immunity to Malaria, built up through evolutionary processes in the indigenous people of Nigeria is the best way (sans DDT) to control, not eradicate Malaria. This very same process is what's responsible genetically for SCD.

Having a 'treatment' for analgesic effect by changing the shape of the sickeled cell is an excellent idea, and doesn't interfere with the natural evolutionary process already underway. As we all know, Evolutionary biology moves slower than than a politician admitting they were wrong. Malaria is a greater concern to the people of Africa, than is SCD. That is a statement of fact. Curing 'SCD' may well not be desirable, if it impinges upon what nature is already doing. This I believe is Nicosan's trump card.

Having not proven that Nicosan works as advertised to the satisfaction of the scientific community, is where XKEM (whomever you want to point a finger at) dropped the ball.

The people of Nigeria know full well that they can still go to their local healer, and get a de facto Nicosan at a fraction of the cost. This is also where XKEM (whomever you want to point a finger at) dropped the ball.

I see no hope for XKEM shareholders to recover their money, not any. I do see a possibility, if Pandey were to regain control, where the old shareholders could invest in a new company and perhaps recover some of their losses.

It should be noted that this same method can be applied to many stocks out there, so an investment in a new 'XKEM' under Pandey, is certainly not a prerequisite for getting one's money back.

I don't like Monty blending the line between humanitarian effort, and an investment. To me, that's reprehensible.

My 2¢

Fight what? I don't see anything to fight

[lmf1264]

Couple of responses:

1). Yes, there's a warehouse full of raw materials, I've shown pictures of them:

http://goo.gl/AKN7

There are a few more in there if you care to look at them. I took those during a plant visit in October (I think, I can't remember off the top of my head), it was my fourth attempt to get in the doors.

2). Xechem was not granted marketing status, so the seven years of exclusivity hasn't started yet. I spoke to the guy that heads the program and he walked me through the process since Xechem owns the Orphan Drug Designation status. Unless Xechem is granted the license back whomever does get it will have to fill out the paperwork all over. It's not a long process, takes a couple of months and it isn't all that difficult to accomplish, it's getting marketing status that takes a bit of time and effort.

3). The Nigerian Government, in many forms, supports Nicosan and will back it. I don't have any specifics that I can discuss because there is nothing that we have been able to work on officially, but in the many meetings that I've had, there has been a lot of interest in working together on a variety of projects. Right not it isn't the Nigerian Government exclusively holding up the process, it's the banks, it's NIPRD, it's the Ministry of Health and it's the guy they all hired as the Receiver to handle turning company over to a qualified group. It's been an incredibly frustrating eight months, but there's been movement as of late, so we'll see what happens...